Aug 21, 09:07
Only BuyersOnly Buyers in Indoco Remedies on NSE
67% of moneycontrol users recommend buying Indoco Remedies.
What's your call on Indoco Remedies today?
Read 14 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2855.25||-1.13||2939.80||2140.35||48,634.91|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Indoco Remedies is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,395.91 crore.The company has reported a standalone sales of Rs 185.86 crore and a Net Profit of Rs 18.55 crore for the quarter ended Mar 2014.
The company management includes Suresh G Kare - Chairman, Aditi Panandikar - Managing Director, Sundeep V Bambolkar - Joint Managing Director, D M Gavaskar - Director, Rajiv P Kakodkar - Director, Sharad P Upasani - Director, Anil M Naik - Director, Anand Nadkarni - Addnl. & Non Exe.Director.
It is listed on the BSE with a BSE Code of 532612 and the NSE with an NSE Code of INDOCO.
Its Registered office is at Indoco House, 166 CST Road,,Kalina, Mumbai,Maharashtra - 400098.
Their Registrars are Link Intime India Pvt. Ltd.